Calamos Advisors’s Castle Biosciences CSTL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-38,876
| Closed | -$1.01M | – | 1226 |
|
|
2022
Q3 | $1.01M | Buy |
+38,876
| New | +$1.01M | ﹤0.01% | 908 |
|
|
2021
Q4 | – | Sell |
-131,984
| Closed | -$8.78M | – | 1092 |
|
|
2021
Q3 | $8.78M | Buy |
131,984
+17,377
| +15% | +$1.16M | 0.04% | 436 |
|
|
2021
Q2 | $8.41M | Buy |
114,607
+8,846
| +8% | +$649K | 0.04% | 424 |
|
|
2021
Q1 | $7.24M | Sell |
105,761
-41,075
| -28% | -$2.81M | 0.04% | 398 |
|
|
2020
Q4 | $9.86M | Sell |
146,836
-4,756
| -3% | -$319K | 0.06% | 317 |
|
|
2020
Q3 | $7.8M | Buy |
151,592
+29,207
| +24% | +$1.5M | 0.05% | 347 |
|
|
2020
Q2 | $4.61M | Buy |
122,385
+34,681
| +40% | +$1.31M | 0.03% | 448 |
|
|
2020
Q1 | $2.61M | Sell |
87,704
-14,789
| -14% | -$441K | 0.02% | 506 |
|
|
2019
Q4 | $3.52M | Buy |
102,493
+70,845
| +224% | +$2.43M | 0.02% | 528 |
|
|
2019
Q3 | $572K | Buy |
+31,648
| New | +$572K | ﹤0.01% | 639 |
|